エイズと臨床研究のジャーナル

HIV to COVID Ezrin Peptide Therapy: Inhibition of Inflammation and Expansion of Adaptive Antiviral Immunity

Abstract

Weoerst Bosen

The emergence of the COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has highlighted the urgent need for effective antiviral therapies and vaccines. In the world of virology, lessons learned from combating other viral infections, such as HIV, can provide valuable insights. One intriguing avenue of research is the potential use of Ezrin Peptide Therapy to inhibit inflammation and expand adaptive antiviral immunity across a range of viral infections, including both HIV and COVID-19.